SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NexStar Pharm(NXTR) -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (254)1/15/1998 1:25:00 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 328
 
Lipo report small increase in Abelcet sales (4Q 15.66M compared to 3Q 13.1M), but actually nothing changed. Except small NXTR holder got scared.

In 3Q for LIPO: US=11.5M and EU=1.6M, and in 4Q US=12.19M and EU=3.47M (~2M from sale to AHP/EU for launch in France/Italy). So where are increase?

mz